B.‐A. Lamberg

2.4k total citations
118 papers, 1.8k citations indexed

About

B.‐A. Lamberg is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Physiology. According to data from OpenAlex, B.‐A. Lamberg has authored 118 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Oncology and 11 papers in Physiology. Recurrent topics in B.‐A. Lamberg's work include Thyroid Disorders and Treatments (55 papers), Thyroid Cancer Diagnosis and Treatment (29 papers) and Growth Hormone and Insulin-like Growth Factors (16 papers). B.‐A. Lamberg is often cited by papers focused on Thyroid Disorders and Treatments (55 papers), Thyroid Cancer Diagnosis and Treatment (29 papers) and Growth Hormone and Insulin-like Growth Factors (16 papers). B.‐A. Lamberg collaborates with scholars based in Finland, Uganda and United States. B.‐A. Lamberg's co-authors include A. Gordin, B Kuhlbäck, K. Liewendahl, Pirkko Saarinen, R Pelkonen, Risto Pelkonen, Otto Wegelius, Ossi Laitinen, Kari I. Kivirikko and Markku Linnoila and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

B.‐A. Lamberg

116 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.‐A. Lamberg Finland 24 1.1k 251 179 177 165 118 1.8k
T. R. Fraser United Kingdom 25 1.1k 1.0× 383 1.5× 230 1.3× 144 0.8× 365 2.2× 61 1.9k
P A Lundberg Sweden 19 845 0.8× 163 0.6× 172 1.0× 123 0.7× 140 0.8× 46 1.8k
D. Reinwein Germany 26 1.7k 1.5× 366 1.5× 215 1.2× 294 1.7× 409 2.5× 157 2.5k
T. S. Danowski United States 23 782 0.7× 408 1.6× 398 2.2× 217 1.2× 286 1.7× 207 2.1k
H Doorenbos Netherlands 22 742 0.7× 326 1.3× 151 0.8× 199 1.1× 392 2.4× 95 1.5k
Julius Sagel United States 19 599 0.5× 149 0.6× 127 0.7× 104 0.6× 231 1.4× 50 1.5k
Harvey C. Knowles United States 24 628 0.6× 193 0.8× 219 1.2× 229 1.3× 233 1.4× 56 1.5k
Marguerite T. Hays United States 22 791 0.7× 266 1.1× 139 0.8× 129 0.7× 129 0.8× 56 1.6k
G. Benker Germany 25 1.6k 1.4× 230 0.9× 133 0.7× 237 1.3× 371 2.2× 99 2.1k
Dimitrios S. Emmanouel United States 24 493 0.4× 472 1.9× 166 0.9× 148 0.8× 318 1.9× 42 1.5k

Countries citing papers authored by B.‐A. Lamberg

Since Specialization
Citations

This map shows the geographic impact of B.‐A. Lamberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.‐A. Lamberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.‐A. Lamberg more than expected).

Fields of papers citing papers by B.‐A. Lamberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.‐A. Lamberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.‐A. Lamberg. The network helps show where B.‐A. Lamberg may publish in the future.

Co-authorship network of co-authors of B.‐A. Lamberg

This figure shows the co-authorship network connecting the top 25 collaborators of B.‐A. Lamberg. A scholar is included among the top collaborators of B.‐A. Lamberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.‐A. Lamberg. B.‐A. Lamberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamberg, B.‐A. & Heikki Solin. (2002). The thyroid gland in Anothomia Mundini and in the Commentaria of Berengarius.. PubMed. 86(2). 171–80. 1 indexed citations
2.
Setälä, Kirsi, et al.. (1992). The value of visual evoked potentials in optic neuropathy of Graves’ disease. Journal of Endocrinological Investigation. 15(11). 821–826. 14 indexed citations
3.
Lamberg, B.‐A.. (1991). Endemic Goitre—Iodine Deficiency Disorders. Annals of Medicine. 23(4). 367–372. 32 indexed citations
4.
Lamberg, B.‐A., M Karkinen-Jääskeläinen, & Kaarle Franssila. (1989). Differentiated Follicle-Derived Thyroid Carcinoma in Children. Acta Paediatrica. 78(3). 419–425. 20 indexed citations
5.
Andersson, Leif C., et al.. (1989). The impact of 25 years of iodine prophylaxis on the adult thyroid weight in Finland. Journal of Endocrinological Investigation. 12(11). 789–793. 6 indexed citations
6.
Mäkinen, Tuulikki, Fredrika Pekonen, Kaarle Franssila, & B.‐A. Lamberg. (1988). Receptors for epidermal growth factor and thyrotropin in thyroid carcinoma. European Journal of Endocrinology. 117(1). 45–50. 22 indexed citations
7.
Bernal, Juan, K. Liewendahl, & B.‐A. Lamberg. (1985). Thyroid Hormone Receptors in Fetal and Hormone Resistant Tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 45(7). 577–583. 3 indexed citations
8.
Wägar, Gustav, et al.. (1982). Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.. PubMed. 14(2). 83–9. 5 indexed citations
9.
Lamberg, B.‐A., et al.. (1977). The Effect of Psychotropic Drugs on the TSH-Response to Thyroliberin (TRH). Neuroendocrinology. 24(2). 90–97. 21 indexed citations
10.
Lamberg, B.‐A., et al.. (1972). THE CONTENT OF THYROID HORMONES AND OTHER IODINATED COMPOUNDS IN THYROID TISSUE IN AUTOIMMUNE THYROIDITIS. European Journal of Endocrinology. 69(2). 309–320. 7 indexed citations
11.
Lamberg, B.‐A., et al.. (1970). THE DEPENDENCE OF URINARY CALCIUM AND OTHER ELECTROLYTES ON ADRENAL FUNCTION DURING ACUTE SODIUM DEPLETION AND LOADING. European Journal of Endocrinology. 64(1). 65–74. 1 indexed citations
12.
Lamberg, B.‐A., et al.. (1970). Regression of Endemic Goitre and of Changes in Iodine Metabolism during 10–15 Years in the East of Finland. Hormone Research in Paediatrics. 1(2). 80–95. 5 indexed citations
13.
Lamberg, B.‐A., et al.. (1965). EFFECT OF A β-1—24TETRACOSAPEPTIDE (30′920-BA CIBA) ON THE PLASMA CORTICOIDS AND THE URINARY 17-KS AND 17-OHCS. European Journal of Endocrinology. 49(3_Suppl). S33–S33. 2 indexed citations
14.
Lamberg, B.‐A., et al.. (1964). EDITORIAL. (BERTEL VON BONSDORFF).. PubMed. 175. SUPPL 412:15–8. 1 indexed citations
15.
Björkstén, Fred, R. Gräsbeck, B.‐A. Lamberg, et al.. (1961). Methods for the Paper Chromatographic and Paper Electrophoretic Separation of Iodide, Iodotyrosines, Iodothryonines and their Derivatives.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 15. 1165–1176. 15 indexed citations
16.
Koskenoja, Mika, et al.. (1960). Myotonic Dystrophy. Acta Medica Scandinavica. 166(2). 151–160. 4 indexed citations
17.
Lamberg, B.‐A.. (1959). The Medical Thyroid Crisis. Acta Medica Scandinavica. 164(6). 479–496. 31 indexed citations
18.
Lamberg, B.‐A., et al.. (1957). The Thyro‐Hypophysial Syndrome.. Acta Medica Scandinavica. 156(5). 377–390. 6 indexed citations
19.
Lamberg, B.‐A.. (1954). [Thyropituitary syndrome in thyrotoxicosis].. PubMed. 51(26). 874–8. 1 indexed citations
20.
Lamberg, B.‐A., et al.. (1953). RELATIONSHIP BETWEEN THE UPTAKE OF P32, THE HISTOLOGICAL CHANGES AND THE CHANGE IN THYROID WEIGHT AFTER THYROTROPHIN TREATMENT. European Journal of Endocrinology. 14(1). 83–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. R. Fraser Breakdown of academic impact, for papers by P A Lundberg Breakdown of academic impact, for papers by D. Reinwein Breakdown of academic impact, for papers by T. S. Danowski Breakdown of academic impact, for papers by H Doorenbos Breakdown of academic impact, for papers by Julius Sagel Breakdown of academic impact, for papers by Harvey C. Knowles Breakdown of academic impact, for papers by Marguerite T. Hays Breakdown of academic impact, for papers by G. Benker Breakdown of academic impact, for papers by Dimitrios S. Emmanouel
Rankless by CCL
2026